Anti-Mullerian Hormone (AMH) Testing Market Likely To Touch New Heights By End Of Forecast Period 2022 – 2030

Anti Mullerian Hormone (AMH): Introduction

  • The anti-Müllerian hormone (AMH) is a glycoprotein-based hormone that is used to determine fertility levels
  • The anti-Mullerian hormone (AMH) test measures the level of anti-müllerian hormone (AMH) in the blood. AMH is produced in the reproductive tissues of both males and females. The role of AMH and whether levels are normal depend on the patient’s age and gender.
  • In females, the roles of the AMH have been the focus of recent attention. AMH plays an important role in the development of sex organs in an unborn baby. In women, the anti-Müllerian hormone test is employed to assess ovarian function and menopausal status; in the evaluation of polycystic ovary syndrome (PCOS) or to evaluate the effectiveness of ovarian cancer treatment. The AMH test is also used to evaluate the presence of external sex organs that are not clearly male or female infants (ambiguous genitalia) and/or function of the testicles in an infant boy.

To gauge the scope of customization in our reports, Ask for a Sample – https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=78175

Key Drivers and Restraints of Global Anti Mullerian Hormone (AMH) testing Market

  • Presently, women have come a long way in terms of their careers and social standing. However, a majority of them are still unaware about their personal well-being and health needs. Government initiatives have changed the entire scenario.
  • On October 18, 2014, the International IMS Society celebrated ‘World Menopause Day’ with the theme ‘Prevention of diseases after menopause’. Rise in initiatives toward women’s education and awareness about their health is likely to generate high demand for diagnostic products including AMH testing.
  • Incidence of women’s health diseases is increasing across the world. According to the Global Burden of Disease Study 2013 (GBD 2013), acute and chronic diseases and injuries occurred in 188 countries between 1990 and 2013 showed the following results: For uterine fibroid, 105,090 (*1000) cases were observed in 1990. The number increased to 171,005 (*1000) in 2013. Moreover, for polycystic ovarian syndrome, the number of cases increased from 80,815 in 1990 to 122,311 (*1000) in 2013.

 Polycystic Ovary Syndrome (PCOS) Evaluation to Lead Global Market

  • The global anti-Mullerian hormone (AMH) testing market can be segmented based on application, end-user, and region
  • In terms of application, the global anti-Mullerian hormone (AMH) testing market can be divided into ovarian function, menopausal status, evaluation of polycystic ovary syndrome (PCOS), ovarian cancer treatment, and others
  • Based on end-user, the global anti-Mullerian hormone (AMH) testing market can be categorized into hospitals, diagnostic laboratories, and others

Are you a start-up willing to make it big in the business? Grab an exclusive PDF Brochure of this report – https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=78175

Asia Pacific to be Lucrative Market

  • The global anti-Mullerian hormone (AMH) testing market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
  • North America dominates the global-anti Mullerian hormone (AMH) testing market. Advancements in diagnostics, rise in awareness about effective use of AMH testing, and favorable reimbursement policies are key factors that make North America a highly attractive market among all regions. Asia Pacific is a highly populated region in the world. This offers significant opportunities for market players to expand their business in the region. Hence, existing global as well as local and regional players have a great scope to focus on this region in order to expand their business.

Pre Book A Report @ https://www.transparencymarketresearch.com/checkout.php?rep_id=78175&ltype=S

Key Players Operating in Global Anti Mullerian Hormone (AMH) testing Market

Leading players in the global anti-Mullerian hormone (AMH) testing market are:

  • Danaher Corporation
  • Becton, Dickinson and Company
  • Biomerieux
  • MenoCheck

More Trending Reports by Transparency Market Research –

About Us

Transparency Market Research is a global market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for several decision makers. Our experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

Our data repository is continuously updated and revised by a team of research experts so that it always reflects latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact

Transparency Market Research,

90 State Street, Suite 700,

Albany, NY 12207

Tel: +1-518-618-1030

USA – Canada Toll Free: 866-552-3453

Email: [email protected]

Website: https://www.transparencymarketresearch.com/